6533b857fe1ef96bd12b4566
RESEARCH PRODUCT
Racing for a SARS‐CoV‐2 vaccine
ÖZlem TüreciUgur Sahinsubject
2019-20 coronavirus outbreakMedicine (General)COVID-19 VaccinesCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCOVID-19QH426-470VirologyR5-920GeneticsHumansMolecular MedicineMedicineInterviewbusinessdescription
Interview with EMBO Members Özlem Türeci and Uğur Şahin, BioNTech, conducted by science journalist Kai Kupferschmidt.
year | journal | country | edition | language |
---|---|---|---|---|
2021-11-01 | EMBO Molecular Medicine |